ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment.

April 25, 2008

NIH Drops Objections To Bill For Research On Environmental Causes of Breast Cancer.

May 23, 2008

NIH Construction: Clinton, NIH Officials Dedicate Vaccine Research Center

June 11, 1999

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

November 14, 2008

Tracors’ Prime Contract Includes $1 Million for Additional Tests

May 17, 1974